1、介入放射学，肝癌、肺癌的介入治疗；

2、急性消化道出血的医学影像学与介入治疗的临床研究；

3、血管疾病的介入治疗

1. Interventional radiology, interventional therapy for liver cancer and lung cancer;

2. Clinical research on medical imaging and interventional treatment of acute gastrointestinal bleeding;

3. Interventional therapy for vascular disease

1、中国医师协会肝癌专委会介入治疗学组，委员

2、第四届中国医师协会介入医师分会，综合介入专家组委员

3、第二届中国研究型医院学会出血专委会，委员，

4、中国抗癌协会第一届肿瘤组织间植入专委会，青年委员

5、上海市抗癌协会第三届肿瘤介入专委会，常务委员

1. Member of the Interventional Therapy Group of the Liver Cancer Special Committee of the Chinese Medical Association

2. Member of the Comprehensive Intervention Expert Group of the 4th Chinese Medical Doctor Association Interventional Physician Branch

3. Member of the 2nd Chinese Research Hospital Association Bleeding Committee,

4. Youth Committee Member of the First Tumor Tissue Implantation Special Committee of the Chinese Anti Cancer Association

5. Executive member of the 3rd Tumor Intervention Committee of Shanghai Anti Cancer Association

留美医学博士，入选上海市医苑新星、上海市青年科技英才扬帆计划、同济大学附属第十人民医院攀登人才计划。擅长肝癌、转移性肝癌、胰腺癌等实体肿瘤及急性消化道出血的介入治疗。主持国家自然科学基金1项，主持上海市卫健委、市科委、同济大学课题多项；以第一作者发表医学论文多篇；晚期胰腺癌介入治疗项目荣获2016年上海市科技进步一等奖1项（10/15）。

Medical Doctor visiting in the United States, selected as Shanghai Medical Rising Star, Shanghai Youth Science and Technology Talents Sailing Program, and the Rising Talent Program of the Tenth People's Hospital Affiliated to Tongji University. He is good at interventional treatment of solid tumors such as liver cancer, metastatic liver cancer, pancreatic cancer, and acute gastrointestinal bleeding and hemoptysis. Presided over 1 National Natural Science Foundation of China, a number of projects of Shanghai Municipal Health Commission, Municipal Science and Technology Commission, and Tongji University; published many medical papers as the first author; interventional treatment for advanced pancreatic cancer project won the 2016 Shanghai Prize for Science and Technology Progress First Class (10/15).

【主持科研项目】

1、2022年上海市崇明区科委, 肝内胆管细胞癌微血管密度与血管造影及预后相关性研究,2022/06—2024/05，CKY2022-35；

2、2020年上海市卫健委临床研究专项，预防性动脉栓塞治疗血管造影阴性急性上消化道出血的安全性及疗效探索，20204Y0167；

3、2020年同济大学智库研究专项基金，信息技术辅助的长三角区域医疗水平同质化可行性研究；

4、2019年国家自然基金（81801805）外泌体源性lncRNA DDX6P调控胰腺癌灌注化疗耐药的功能和机制研究；

5、2018年同济大学附属第十人民医院攀登人才计划，综合介入治疗晚期胰腺癌的临床策略优化研究

【Hosting scientific research projects】

1. Study on the Correlation between Microvascular Density, Angiography, and Prognosis of Intrahepatic Cholangiocarcinoma, Chongming District Science and Technology Commission, Shanghai, 2022, June 2022-2024, May 2024, CKY2022-35；

2. 2020 Shanghai Municipal Health Commission's clinical research project, The safety and efficacy of preventive arterial embolization in the treatment of acute upper gastrointestinal bleeding with negative angiography, 20204Y0167;

3. 2020 Tongji University Think Tank Research Special Fund, Information technology-assisted feasibility study on the homogeneity of medical care in the Yangtze River Delta region;

4. In 2019, the National Natural Science Foundation of China (81801805) exosome-derived lncRNA DDX6P regulates the function and mechanism of pancreatic cancer infusion chemotherapy resistance;

5. In 2018, The Rising Talents Program of the Tenth People's Hospital Affiliated to Tongji University, Comprehensive interventional treatment of advanced pancreatic cancer clinical strategy optimization research

【代表性论著】

1. 张炜,徐珉杰,韩世龙.术前Glasgow-Blatchford和AIMS65评分对介入治疗非静脉曲张性上消化道出血患者的预后评估[J].介入放射学杂志,2024,33(09):1005-1008.（通讯）

2. Han S, Cao C, Liu R, Yuan Y, Pan L, Xu M, Hu C, Zhang X, Li M, Zhang X. GAS41 mediates proliferation and GEM chemoresistance via H2A.Z.2 and Notch1 in pancreatic cancer. Cell Oncol (Dordr).2022 Jun; 45(3):429-446. doi: 10.1007/s13402-022-00675-8.

3. Han S, Cao C, Yuan Y, et al. Transcatheter Arterial Infusion Combined With Radioactive Particles in the Treatment of Advanced Body/Tail Pancreatic Cancer: A Retrospective Cohort Study. Pancreas. 2021;50(6):822-826.

4. Cao C*, Han S*, Yuan Y, Wu Y, Lian W, Zhang X, Pan L, Li M. Downregulated Circular RNA hsa_circ_0000291 Suppresses Migration And Proliferation Of Gastric Cancer Via Targeting The miR-183/ITGB1 Axis. Cancer Manag Res. 2019. 14;11:9675-9683.

5. Han S, Zhang X, Li M. Research and application progress in PLGA embolic microspheres. Frontiers in Bioscience 2016, June 1(21), 1102-1109.

6. Han S, Cao C, Li M et al. ROBO3 Promotes Growth and Metastasis of Pancreatic Carcinoma. Cancer Lett. 2015 Sep 28;366(1):61- 70

7. 韩世龙, 朱晓黎，张猛等. 经皮注射医用臭氧治疗兔VX2移植瘤的实验研究. 介入放射学杂志, 2013, 22(3): 227-231.

【Published paper】

1. Zhang Wei, Xu Minjie, Han Shilong Preoperative Glasgow Blatchford and AIMS65 scores for prognostic evaluation of patients with non variceal upper gastrointestinal bleeding undergoing interventional therapy [J]. Journal of Interventional Radiology, 2024, 33 (09): 1005-1008

2. Han S, Cao C, Liu R, Yuan Y, Pan L, Xu M, Hu C, Zhang X, Li M, Zhang X. GAS41 mediates proliferation and GEM chemoresistance via H2A.Z.2 and Notch1 in pancreatic cancer. Cell Oncol (Dordr).2022 Jun; 45(3):429-446. doi: 10.1007/s13402-022-00675-8.

3. Han S, Cao C, Yuan Y, et al. Transcatheter Arterial Infusion Combined With Radioactive Particles in the Treatment of Advanced Body/Tail Pancreatic Cancer: A Retrospective Cohort Study. Pancreas. 2021;50(6):822-826.

4. Cao C*, Han S*, Yuan Y, Wu Y, Lian W, Zhang X, Pan L, Li M. Downregulated Circular RNA hsa_circ_0000291 Suppresses Migration And Proliferation Of Gastric Cancer Via Targeting The miR-183/ITGB1 Axis. Cancer Manag Res. 2019. 14;11:9675-9683.

5. Han S, Zhang X, Li M. Research and application progress in PLGA embolic microspheres. Frontiers in Bioscience 2016, June 1(21), 1102-1109.

6. Han S, Cao C, Li M et al. ROBO3 Promotes Growth and Metastasis of Pancreatic Carcinoma. Cancer Lett. 2015 Sep 28;366(1):61- 70

7. Han Shilong, Zhu Xiaoli, Zhang Meng, etc Experimental study on percutaneous injection of medical ozone for the treatment of rabbit VX2 transplant tumors Journal of Interventional Radiology, 2013, 22 (3): 227-231